13. 多発性硬化症/視神経脊髄炎
[臨床試験数:3,050,薬物数:2,147(DrugBank:348),標的遺伝子数:244,標的パスウェイ数:228

Searched query = "Multiple sclerosis/Neuromyelitis optica", "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01448252
(ClinicalTrials.gov)
May 20025/10/2011T Cell Vaccination in Patients With Progressive Multiple SclerosisAutologous T Cell Vaccination With Line Specific for 9 Myelin Peptides in Patients With Progressive / Relapsing Multiple SclerosisMultiple SclerosisBiological: multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides);Biological: T cell vaccinationHadassah Medical OrganizationNULLCompleted18 Years60 YearsBoth30Phase 1;Phase 2Israel
2NCT00228228
(ClinicalTrials.gov)
May 200226/9/2005TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple SclerosisT-Cell Vaccination in the Treatment of Probable Multiple SclerosisMultiple SclerosisBiological: T cell vaccinationSheba Medical CenterNULLRecruiting15 Years50 YearsBoth80Phase 3Israel